Literature DB >> 25461956

Differential expression of microRNAs in ischemic heart disease.

Minwoo A Song1, Alexandra N Paradis1, Maresha S Gay1, John Shin1, Lubo Zhang2.   

Abstract

Recent studies provide evidence that ischemic preconditioning (IP) and ischemia/reperfusion (IR) injury lead to altered expression of microRNAs (miRNAs) that affect the survival and recovery of cardiomyocytes. These endogenous ∼22-nucleotide noncoding RNAs negatively regulate gene expression via degradation and translational inhibition of their target mRNAs. miRNAs are involved in differentiation, proliferation, electrical conduction, angiogenesis and apoptosis. These pathways can lead to physiological and pathological adaptations. This review intends to explore several facets of miRNA expression and the underlying mechanisms involved in IR injury, as well as IP as a cardioprotective strategy. In addition, we will investigate miRNA interaction with the renin-angiotensin system and the potential use of miRNAs in developing sensitive biomarkers for cardiovascular disease.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25461956      PMCID: PMC4336590          DOI: 10.1016/j.drudis.2014.10.004

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  119 in total

Review 1.  BCL-2 family members and the mitochondria in apoptosis.

Authors:  A Gross; J M McDonnell; S J Korsmeyer
Journal:  Genes Dev       Date:  1999-08-01       Impact factor: 11.361

2.  The angiotensin II AT2 receptor is an AT1 receptor antagonist.

Authors:  S AbdAlla; H Lother; A M Abdel-tawab; U Quitterer
Journal:  J Biol Chem       Date:  2001-08-15       Impact factor: 5.157

Review 3.  Arresting angiotensin type 1 receptors.

Authors:  Walter G Thomas; Hongwei Qian
Journal:  Trends Endocrinol Metab       Date:  2003-04       Impact factor: 12.015

4.  Exercise training restores ischemic preconditioning in the aging heart.

Authors:  P Abete; C Calabrese; N Ferrara; A Cioppa; P Pisanelli; F Cacciatore; G Longobardi; C Napoli; F Rengo
Journal:  J Am Coll Cardiol       Date:  2000-08       Impact factor: 24.094

5.  Asymmetry in the assembly of the RNAi enzyme complex.

Authors:  Dianne S Schwarz; György Hutvágner; Tingting Du; Zuoshang Xu; Neil Aronin; Phillip D Zamore
Journal:  Cell       Date:  2003-10-17       Impact factor: 41.582

6.  Functional siRNAs and miRNAs exhibit strand bias.

Authors:  Anastasia Khvorova; Angela Reynolds; Sumedha D Jayasena
Journal:  Cell       Date:  2003-10-17       Impact factor: 41.582

Review 7.  Crosstalk between insulin and angiotensin II signalling systems.

Authors:  F Folli; M J Saad; L Velloso; H Hansen; O Carandente; E P Feener; C R Kahn
Journal:  Exp Clin Endocrinol Diabetes       Date:  1999       Impact factor: 2.949

Review 8.  A practical approach to risk assessment to prevent coronary artery disease and its complications.

Authors:  MacRae F Linton; Sergio Fazio
Journal:  Am J Cardiol       Date:  2003-07-03       Impact factor: 2.778

9.  The nuclear RNase III Drosha initiates microRNA processing.

Authors:  Yoontae Lee; Chiyoung Ahn; Jinju Han; Hyounjeong Choi; Jaekwang Kim; Jeongbin Yim; Junho Lee; Patrick Provost; Olof Rådmark; Sunyoung Kim; V Narry Kim
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

10.  Human let-7 stem-loop precursors harbor features of RNase III cleavage products.

Authors:  Eugenia Basyuk; Florence Suavet; Alain Doglio; Rémy Bordonné; Edouard Bertrand
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

View more
  23 in total

Review 1.  Mechanisms and therapeutic potential of microRNAs in hypertension.

Authors:  Lijun Shi; Jingwen Liao; Bailin Liu; Fanxing Zeng; Lubo Zhang
Journal:  Drug Discov Today       Date:  2015-05-21       Impact factor: 7.851

Review 2.  Clinical value of non-coding RNAs in cardiovascular, pulmonary, and muscle diseases.

Authors:  Sébastien Bonnet; Olivier Boucherat; Roxane Paulin; Danchen Wu; Charles C T Hindmarch; Stephen L Archer; Rui Song; Joseph B Moore; Steeve Provencher; Lubo Zhang; Shizuka Uchida
Journal:  Am J Physiol Cell Physiol       Date:  2019-09-04       Impact factor: 4.249

Review 3.  Ischemia/Reperfusion.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

4.  MiR-146b protects cardiomyocytes injury in myocardial ischemia/reperfusion by targeting Smad4.

Authors:  Yun-Feng Di; De-Cai Li; Yan-Qing Shen; Chun-Lei Wang; Da-Yong Zhang; An-Quan Shang; Teng Hu
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

Review 5.  Cellular and molecular mechanisms of endothelial ischemia/reperfusion injury: perspectives and implications for postischemic myocardial protection.

Authors:  Qin Yang; Guo-Wei He; Malcolm John Underwood; Cheuk-Man Yu
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

Review 6.  Emerging role of hydrogen sulfide-microRNA crosstalk in cardiovascular diseases.

Authors:  Bryan T Hackfort; Paras K Mishra
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-01-22       Impact factor: 4.733

Review 7.  Corticosteroids and perinatal hypoxic-ischemic brain injury.

Authors:  Katherine R Concepcion; Lubo Zhang
Journal:  Drug Discov Today       Date:  2018-05-17       Impact factor: 7.851

Review 8.  Gestational Hypoxia and Developmental Plasticity.

Authors:  Charles A Ducsay; Ravi Goyal; William J Pearce; Sean Wilson; Xiang-Qun Hu; Lubo Zhang
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

Review 9.  Exosomes in atrial fibrillation: therapeutic potential and role as clinical biomarkers.

Authors:  Kun Xiang; Muhammad Akram; Walaa Fikry Elbossaty; Jinfu Yang; Chengming Fan
Journal:  Heart Fail Rev       Date:  2021-07-12       Impact factor: 4.654

Review 10.  Antioxidant responses and cellular adjustments to oxidative stress.

Authors:  Cristina Espinosa-Diez; Verónica Miguel; Daniela Mennerich; Thomas Kietzmann; Patricia Sánchez-Pérez; Susana Cadenas; Santiago Lamas
Journal:  Redox Biol       Date:  2015-07-21       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.